Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,707 | 69,530 | 67,241 | 60,535 | 143,312 |
| Marketable Securities | 230,859 | 188,387 | 270,500 | 306,165 | 342,510 |
| Receivables | N/A | N/A | N/A | 2,000 | 2,000 |
| TOTAL | $353,756 | $266,343 | $346,538 | $375,272 | $492,338 |
| Non-Current Assets | |||||
| PPE Net | 6,868 | 8,102 | 9,908 | 10,884 | 4,832 |
| Other Non-Current Assets | 38,066 | 42,047 | 46,121 | 50,314 | 2,985 |
| TOTAL | $44,934 | $50,149 | $56,029 | $61,198 | $7,817 |
| Total Assets | $398,690 | $316,492 | $402,567 | $436,470 | $500,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,182 | 1,601 | 2,785 | 4,453 | 3,226 |
| Accrued Expenses | 17,759 | 16,497 | 15,401 | 17,495 | 9,887 |
| TOTAL | $21,679 | $38,170 | $45,938 | $55,545 | $40,690 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 17,618 | 25,670 | 31,792 | 26,022 |
| Other Non-Current Liabilities | 30,832 | 34,039 | 36,838 | 39,361 | 0 |
| TOTAL | $30,832 | $78,805 | $103,521 | $131,449 | $114,718 |
| Total Liabilities | $52,511 | $116,975 | $149,459 | $186,994 | $155,408 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 142,689 | 108,108 | 106,718 | 88,203 | 87,708 |
| Common Shares | 136 | 108 | 102 | 88 | 88 |
| Retained earnings | -603,152 | -501,558 | -371,256 | -269,512 | -161,336 |
| Other shareholders' equity | 224 | 336 | 186 | -3,705 | -765 |
| TOTAL | $346,179 | $199,517 | $253,108 | $249,476 | $344,747 |
| Total Liabilities And Equity | $398,690 | $316,492 | $402,567 | $436,470 | $500,155 |